Equity
GENOBO paid out €49,326 in dividends. That is 66% of the 2025 profit.
GENOBO paid out €49,326 in dividends. That is 66% of the 2025 profit.
Back in profit in 2025, after a loss of €8,041 in 2024.
The micro format states no turnover.
Of this, €72,789 falls due within a year.
Short-term debts fell from €1.8m to €72,789.
Higher net result than 87% of companies in real estate. Sector median €6,006 · 17,166 companies.
The dashed line is the sector median: 0.2% across 26,627 companies (NACE 68, micro).
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 68, micro). It does better than 36% of them on solvency, 74% on liquidity, 80% on profitability and 89% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 6,713 companies had the same profile as GENOBO has now. Each dot stands for 17 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of GENOBO itself is lower: 0.1% within 12 months. It rests on far more data about GENOBO than the profile alone.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,713 companies, not a prediction for GENOBO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is ample, with a current ratio of 5.62 (1.16 in 2024), above the usual 1.5. Short-term debt is 17.7% and cash 14% of total assets. However, 85% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 7 accounts on average 24 days before the deadline. In the sector (NACE 68), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
| Company | Total assets | Gross margin | Solvency | Staff |
|---|---|---|---|---|
| GENOBO Hechtel-Eksel | €412,113 | €94,337 | 15.0% | - |
| 4 REBUS Oudsbergen | €419,141 | €97,615 | 34.7% | - |
| JOCHEMS PROJECT MANAGEMENT Genk | €460,821 | €72,502 | 18.3% | - |
| OF INVEST Heusden-Zolder | €472,947 | €114,490 | 47.7% | - |
| EGU CONSTRUCT Welkenraedt | €416,280 | €110,494 | 31.7% | - |
| SV2 Maldegem | €431,931 | €99,619 | 28.7% | - |
| M.G.I. Bièvre | €397,190 | €105,648 | 66.9% | - |
These companies have the same main activity as GENOBO: development of residential building projects (NACE 68121). They are comparable in size and age: total assets between €397,000 and €473,000, founded between 2018 and 2019.
GENOBO files the micro format. That format states no turnover. The gross margin rose from -€3,526 in 2019 to €94,337 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.